UK AstraZeneca vaccine plant says production unaffected by suspect package

By Phil Noble WREXHAM, Wales (Reuters) - A suspicious package at an AstraZeneca COVID-19 vaccine plant in Wales which forced a temporary suspension of manufacturing has been made safe and production schedules of the shots have not been affected, the company Wockhardt UK said on Wednesday. The Wockhardt plant in Wrexham provides so-called fill-and-finish capacity for AstraZeneca's UK supply chain, which is the final manufacturing step of putting vaccines into vials or syringes and packaging them

Reuters January 28, 2021 00:11:10 IST
UK AstraZeneca vaccine plant says production unaffected by suspect package

UK AstraZeneca vaccine plant says production unaffected by suspect package

By Phil Noble

WREXHAM, Wales (Reuters) - A suspicious package at an AstraZeneca COVID-19 vaccine plant in Wales which forced a temporary suspension of manufacturing has been made safe and production schedules of the shots have not been affected, the company Wockhardt UK said on Wednesday.

The Wockhardt plant in Wrexham provides so-called fill-and-finish capacity for AstraZeneca's UK supply chain, which is the final manufacturing step of putting vaccines into vials or syringes and packaging them.

Wockhardt said there had been a partial evacuation of its site after it received package on Wednesday morning, and that manufacturing was paused while the package was investigated.

"We can now confirm that the package was made safe and staff are now being allowed back into the facility," Wockhardt UK said in a statement. "This temporary suspension of manufacturing has in no way affected our production schedule."

Police, who called out the bomb disposal squad to the incident, did not clarify whether the package had posed a threat but said the contents would be analysed and there would be an investigation into the circumstances.

"There are no wider concerns for public safety," a police statement said.

Last week, there was flooding near the Wockhardt site but its manufacturing of the vaccine was unaffected.

AstraZeneca has agreed to supply Britain with 100 million doses of the COVID vaccine it developed with Oxford University, with the shots forming the central plank of its mass vaccination programme.

AstraZeneca is currently in a dispute with the European Union after it cut vaccine supplies to the bloc due to production issues at its Belgian factory.

(Reporting by Alistair Smout, Michael Holden and Guy Faulconbridge; Editing by Estelle Shirbon and Angus MacSwan)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Subscribe to Moneycontrol Pro at ₹499 for the first year. Use code PRO499. Limited period offer. *T&C apply

also read

Thyssenkrupp ends talks with UK's Liberty on steel unit sale
Business

Thyssenkrupp ends talks with UK's Liberty on steel unit sale

By Christoph Steitz, Tom Käckenhoff and Arno Schuetze FRANKFURT (Reuters) - German conglomerate Thyssenkrupp ended talks to sell its steel division to Britain's Liberty Steel due to differences over value, the latest setback in efforts to consolidate the European sector. Liberty Steel, led by commodities tycoon Sanjeev Gupta, last month submitted a firmed-up non-binding bid for Thyssenkrupp's steel unit, Europe's second biggest in terms of sales, which sources said included commitments to protect jobs and sites.

Factbox: Stonks in Washington: Deciphering Reddit's WallStreetBets lingo
Business

Factbox: Stonks in Washington: Deciphering Reddit's WallStreetBets lingo

(Reuters) - Reddit trading lingo may filter in to Washington on Thursday when top hedge fund managers, the head of Robinhood and Roaring Kitty himself are set to give testimony before U.S. House of Representatives lawmakers.

Brent gives up gains after rising above $65 on Texas freeze
Business

Brent gives up gains after rising above $65 on Texas freeze

By Stephanie Kelly NEW YORK (Reuters) - Oil prices steadied on Thursday, with Brent edging back from a 13-month high, after a sharp drop in U.S. crude inventories supported prices, while buying spurred by a cold snap in the largest U.S. energy-producing state petered out.